Free Trial

Cassava Sciences (SAVA) Insider Trading & Ownership

Cassava Sciences logo
$26.05 -1.95 (-6.96%)
(As of 11/20/2024 ET)

Cassava Sciences (NASDAQ:SAVA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.20%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$3.93 M
Number Of
Insiders Selling
(Last 3 Years)
0
Get SAVA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cassava Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SAVA Insider Buying and Selling by Quarter

Cassava Sciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/23/2023Sanford RobertsonDirectorBuy42,000$12.46$523,500.00  
8/21/2023Richard BarryDirectorBuy2,668$12.00$32,016.00  
8/21/2023Richard BarryDirectorBuy2,668$12.00$32,016.00  
3/6/2023Richard BarryDirectorBuy16,190$18.66$302,174.79  
8/23/2022James William KupiecInsiderBuy3,500$17.46$61,100.00  
8/23/2022Richard BarryDirectorBuy50,622$16.99$860,212.41  
8/12/2022Eric SchoenCFOBuy3,500$14.25$49,875.00  
8/12/2022Sanford RobertsonDirectorBuy140,000$14.78$2,069,000.00  
(Data available from 1/1/2013 forward)

SAVA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Cassava Sciences includes Eric Schoen, James William Kupiec, Richard Barry, and Sanford Robertson. Learn more on insiders at SAVA.

12.20% of Cassava Sciences stock is owned by insiders. Learn more on SAVA's insider holdings.

The following insiders have purchased SAVA shares in the last 24 months: Richard Barry ($366,206.79), and Sanford Robertson ($523,500.00).

Insiders have purchased a total of 63,526 SAVA shares in the last 24 months for a total of $889,706.79 bought.

Cassava Sciences Key Executives

  • Mr. Remi Barbier (Age 64)
    Founder, Chairman, President & CEO
    Compensation: $1.2M
  • Mr. Eric J. Schoen (Age 56)
    Chief Financial Officer
    Compensation: $460k
  • Mr. R. Christopher Cook (Age 60)
    Senior VP, Company Secretary & General Counsel
    Compensation: $425k
  • Dr. James W. Kupiec M.D. (Age 71)
    Chief Medical Officer
    Compensation: $435k
  • Dr. George Thornton Ph.D.
    Senior Vice President of Technology
  • Mr. Michael Zamloot
    Senior Vice President of Technical Operations
  • Dr. Michael Marsman Pharm.D.
    Senior Vice President of Regulatory Affairs
  • Dr. Lindsay H. Burns Ph.D.
    Senior Vice President of Neuroscience


This page (NASDAQ:SAVA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners